Stephen V Liu reports ADRIATIC subset data showing consolidation durvalumab after chemoradiation in limited-stage small cell lung cancer improved overall survival across multiple treatment subgroups.
Subset data from ADRIATIC @JTOonline.
Consolidation durvalumab after chemoradiation in LS-SCLC improved OS across subsets
This finding is one of many signals tracked across Healthcare. The live feed updates every few hours with new expert voices, debates, and emerging ideas.
← Back to Healthcare